“3. The Referee has been unable to secure reliable clinical evidence that Iron Cacodylate is a serviceable preparation. A search of the available literature for the past fifteen years has been made, also Drs. Edsall, Longcope, Stengel, Hoover, Phillips and Miller have been consulted. These physicians know nothing of its use.
“4. In view of the above, it appears to the Referee that Iron Cacodylate is an irrational and useless method of the administration of iron and arsenic.”
The Council adopted the report of the referee and directed that iron cacodylate be omitted from the 1921 edition of New and Nonofficial Remedies.—(From Reports of Council on Pharmacy and Chemistry, 1920, p. 62.)
LIBRADOL
Report of the Council on Pharmacy and Chemistry
The Council has authorized for publication the following report which explains why Libradol was found ineligible for New and Nonofficial Remedies.
W. A. Puckner, Secretary.
Libradol is manufactured by Lloyd Bros., Cincinnati. According to a circular (a “readily removable” label) which accompanies the trade package, its “uses” are: “In colds, croup and acute bronchitis. In local congestions; in lung trouble, in acute inflammations of this or any other organ, especially if pain or soreness be present. In lumbago, sciatica, or in rheumatic pains of the joints or muscles. Applied to the forehead, it induces sleep.”
Libradol is offered in two forms, “Libradol Mild” for infants and supersensitive persons which is said to be “destitute of drug energy” and Libradol “Regular” which is “highly medicated,” the “constituents” being “DRACONTIUM, SANGUINARIA, CEPHAELIS, MELALEUCA, LOBELIA, LAURUS, CAPSICUM, TOBACCO.”